Verity Asset Management, Inc.
Source: SEC Form 13F · as of Mar 2026Verity Asset Management, Inc. holds 18 biotech & pharma companies tracked by BioSniper, totaling $19.8M in value as of Mar 2026 (SEC Form 13F).
Companies held
18
Total value held
$19.8M
| Company | Shares | Value |
|---|---|---|
| HALOHALOZYME THERAPEUTICS, INC. | 53,142 | $3.4M |
| AMGNAMGEN INC | 8,218 | $2.9M |
| PMPhilip Morris International Inc | 11,268 | $1.9M |
| BMYBRISTOL MYERS SQUIBB CO | 30,333 | $1.8M |
| JNJJOHNSON & JOHNSON | 6,344 | $1.6M |
| GILDGILEAD SCIENCES, INC. | 10,432 | $1.5M |
| GSKGSK plc American Depositary Shares (Each representing two Ordinary Shares) | 24,730 | $1.4M |
| MRKMerck & Co., Inc. | 9,202 | $1.1M |
| RPRXRoyalty Pharma plc | 13,431 | $644K |
| ABBVAbbVie Inc. | 2,838 | $617K |
| MDGLMADRIGAL PHARMACEUTICALS, INC. | 1,164 | $609K |
| IBRXImmunityBio, Inc. | 68,752 | $527K |
| LLYELI LILLY & Co | 544 | $500K |
| NVONovo Nordisk A/S | 10,925 | $401K |
| ZTSZoetis Inc. | 2,861 | $338K |
| AZNASTRAZENECA PLC | 1,683 | $332K |
| NVSNovartis AG | 1,988 | $304K |
| ATAIAtai Beckley N.V. | 10,000 | $35K |
13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.